Literature DB >> 18492905

Local tumor progression after radiofrequency ablation of liver tumors: analysis of morphologic pattern and site of recurrence.

Shiu Kong Kei1, Hyunchul Rhim, Dongil Choi, Won Jae Lee, Hyo K Lim, Young-sun Kim.   

Abstract

OBJECTIVE: The purpose of our study was to assess the morphologic pattern and exact site of local tumor progression with relation to various risk factors after radiofrequency ablation of liver tumors.
CONCLUSION: Local tumor progression after radiofrequency ablation shows mostly the peripheral nodular type. The site of local tumor progression shows a higher concordance rate with insufficient ablative margin than contiguous vessel and subcapsular location.

Entities:  

Mesh:

Year:  2008        PMID: 18492905     DOI: 10.2214/AJR.07.2798

Source DB:  PubMed          Journal:  AJR Am J Roentgenol        ISSN: 0361-803X            Impact factor:   3.959


  28 in total

1.  CT-guided radiofrequency ablation as a salvage treatment of colorectal cancer hepatic metastases developing after hepatectomy.

Authors:  Constantinos T Sofocleous; Elena N Petre; Mithat Gonen; Karen T Brown; Stephen B Solomon; Anne M Covey; William Alago; Lynn A Brody; Raymond H Thornton; Michael D'Angelica; Yuman Fong; Nancy E Kemeny
Journal:  J Vasc Interv Radiol       Date:  2011-04-22       Impact factor: 3.464

2.  Margin size is an independent predictor of local tumor progression after ablation of colon cancer liver metastases.

Authors:  Xiaodong Wang; Constantinos T Sofocleous; Joseph P Erinjeri; Elena N Petre; Mithat Gonen; Kinh G Do; Karen T Brown; Anne M Covey; Lynn A Brody; William Alago; Raymond H Thornton; Nancy E Kemeny; Stephen B Solomon
Journal:  Cardiovasc Intervent Radiol       Date:  2012-04-26       Impact factor: 2.740

Review 3.  Thermal Ablation in the Management of Colorectal Cancer Patients with Oligometastatic Liver Disease.

Authors:  Elena Nadia Petre; Constantinos Sofocleous
Journal:  Visc Med       Date:  2017-02-03

4.  Percutaneous Image-Guided Cryoablation of Hepatic Tumors: Single-Center Experience With Intermediate to Long-Term Outcomes.

Authors:  Daniel I Glazer; Servet Tatli; Paul B Shyn; Mark G Vangel; Kemal Tuncali; Stuart G Silverman
Journal:  AJR Am J Roentgenol       Date:  2017-09-27       Impact factor: 3.959

5.  Heat stress induced, ligand-independent MET and EGFR signalling in hepatocellular carcinoma.

Authors:  Scott M Thompson; Danielle E Jondal; Kim A Butters; Bruce E Knudsen; Jill L Anderson; Matthew P Stokes; Xiaoying Jia; Joseph P Grande; Lewis R Roberts; Matthew R Callstrom; David A Woodrum
Journal:  Int J Hyperthermia       Date:  2017-11-06       Impact factor: 3.914

6.  Heat Stress and Thermal Ablation Induce Local Expression of Nerve Growth Factor Inducible (VGF) in Hepatocytes and Hepatocellular Carcinoma: Preclinical and Clinical Studies.

Authors:  Scott M Thompson; Danielle E Jondal; Kim A Butters; Bruce E Knudsen; Jill L Anderson; Lewis R Roberts; Matthew R Callstrom; David A Woodrum
Journal:  Gene Expr       Date:  2018-07-04

Review 7.  Laser ablation for small hepatocellular carcinoma: State of the art and future perspectives.

Authors:  Giovan Giuseppe Di Costanzo; Giampiero Francica; Claudio Maurizio Pacella
Journal:  World J Hepatol       Date:  2014-10-27

8.  Ultrasound-based relative elastic modulus imaging for visualizing thermal ablation zones in a porcine model.

Authors:  Jingfeng Jiang; Chris Brace; Anita Andreano; Ryan J DeWall; Nick Rubert; Ted G Fisher; Tomy Varghese; Fred Lee; Timothy J Hall
Journal:  Phys Med Biol       Date:  2010-03-30       Impact factor: 3.609

9.  Radiofrequency Ablation of Hepatic Tumor: Subjective Assessment of the Perilesional Vascular Network on Contrast-Enhanced Computed Tomography Before and After Ablation Can Reliably Predict the Risk of Local Recurrence.

Authors:  Sireesha Yedururi; Silanath Terpenning; Sanjay Gupta; Patricia Fox; Sooyoung Shin Martin; Claudius Conrad; Evelyne M Loyer
Journal:  J Comput Assist Tomogr       Date:  2017 Jul/Aug       Impact factor: 1.826

10.  Ablative margin states by magnetic resonance imaging with ferucarbotran in radiofrequency ablation for hepatocellular carcinoma can predict local tumor progression.

Authors:  Masahiko Koda; Shiho Tokunaga; Kennichi Miyoshi; Manabu Kishina; Yuki Fujise; Jun Kato; Tomomitsu Matono; Yoshikazu Murawaki; Suguru Kakite; Eijiro Yamashita
Journal:  J Gastroenterol       Date:  2013-01-22       Impact factor: 7.527

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.